When a patient is diagnosed with alcoholic hepatitis, doctors must act quickly. They often use specific scoring systems to predict how well a patient might survive the next few weeks or months. These scores help medical teams prioritize care and manage treatment plans for people with severe liver disease.
A large review compared three common tools: Maddrey's discriminant function (MDF), MELD, and MELD-Na. Each tool looks at different factors to predict mortality at 28 days and 90 days. While the scores showed different levels of sensitivity and specificity across the board, the study found no significant statistical difference when comparing the overall accuracy of these three methods.
Because the tools performed similarly in terms of overall area under the curve, it suggests that while each method has its own way of calculating risk, they provide comparable predictive power. This information helps doctors understand which tools are available for assessing patient outcomes in liver disease.
